Next Article in Journal
Pharmacological Evaluation of the Anticancer Activity of Extracts and Fractions of Lannea barteri Oliv. (Anacardiaceae) on Adherent Human Cancer Cell Lines
Next Article in Special Issue
Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation
Previous Article in Journal
Ultrafast Backbone Protonation in Channelrhodopsin-1 Captured by Polarization Resolved Fs Vis-pump—IR-Probe Spectroscopy and Computational Methods
Previous Article in Special Issue
Diagnostic Potential of FT-IR Fingerprinting in Botanical Origin Evaluation of Laurus nobilis L. Essential Oil is Supported by GC-FID-MS Data
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Modified Clerodanes from the Essential Oil of Dodonea viscosa Leaves

1
Laboratoire de Chimie des Substances Naturelles et des Sciences des Aliments, Faculté des Sciences et Technologies, Université de la Réunion, 15 Avenue René Cassin, CS 92003, 97744 St Denis, Messag CEDEX 9, La Réunion, France
2
Institut de Chimie des Substances Naturelles, CNRS, 91110 Gif-sur-Yvette, France
3
School of Chemistry, Tel Aviv University, Tel Aviv 69978, Israel
4
Parc national de La Réunion, Secteur Nord, 165 allée des spinelles Bellepierre, 97400 St-Denis, France
*
Author to whom correspondence should be addressed.
Submission received: 27 December 2019 / Revised: 7 February 2020 / Accepted: 11 February 2020 / Published: 14 February 2020

Abstract

:
Dodonea viscosa (L.) Jacq from Reunion Island (Indian Ocean) was investigated for its leaf essential oil composition. The plant was extracted by hydrodistillation and its essential oil analysed by gas chromatography coupled to mass spectrometry. This study revealed that oxygenated nor-diterpenes and diterpenes were one of the major chemical classes (> 50%) mainly consisting of three modified cyclopropylclerodanes containing a bicyclo[5.4.0]undecane ring system: one new furanoid norditerpene, dodovisate C, and two furanoid diterpenes, the known methyl dodovisate A and the new methyl iso-dodovisate A. These three compounds were isolated by liquid chromatography and their structures established on the basis of spectroscopic studies. The absolute configuration of dodovisate C was elucidated through a joint experimental and theoretical (B3LYP/6-311+G(d,p)) electronic circular dichroism study. The relative configurations of methyl dodovisate A and methyl iso-dodovisate A were determined using linear regressions of theoretical chemical shifts versus experimental values with the (B3LYP/6-311+G(d,p)) method.

Graphical Abstract

1. Introduction

Dodonea viscosa is an ever-green shrub belonging to the family Sapindaceae with a cosmopolitan distribution in tropical, subtropical and warm temperate regions of Africa, India, Southern Asia, Australasia and South America. It is also met with throughout Reunion Island (Indian Ocean), often growing wild, but generally cultivated in the form of a hedge for ornamenting gardens, roads, etc. Moreover, preliminary observations of the wild populations, in various localities on Reunion Island, have shown a significant morphological diversity of the plant. Three main morphotypes can be distinguished according to the leaf shape: morphotype 1 (80–110 mm long, 15–25 mm wide), morphotype 2 (85–130 mm long, 10–13 mm wide) and morphotype 3 (120–150 mm long, 3–6 mm wide)
The plant possesses a great repute in folk medicine not only in India [1] Pakistan [2], Ethiopia [3,4], Tanzania [5], South Africa [6,7,8,9,10], Peru [11], Ecuador [12], Brazil [13], Mexico [14,15], but also in Madagascar [16], Mauritius [17,18], Rodrigues [19], and Reunion Island [20,21,22,23,24,25]. In Reunion Island, this plant is locally really appreciated for its healing virtues: it is considered to be very efficacious against arthrosis, gout, rheumatism, haemorrhoid, haematoma, asthma, sinusitis, and nephritic colic. It is also reputed to have hypertensive properties. Owing to its medicinal properties, this species has been registered in the French Pharmacopoeia since 2012 [26,27].
Since it is widely used in folk medicine, the plant has been extensively investigated for its biological and pharmacological properties [3,5,7,15,18,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44], as well as its chemical composition. According to previous phytochemical studies, the species contains diterpenes, sapogenins, saponins, sterols, triterpenes, flavonoids and other phenolic compounds [37,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63]. Concerning more specifically volatile compounds from Dodonea viscosa, only one study devoted to essential oil sample from Saudi Arabia has been carried out [64]. This study indicated that the leaf essential oil of the plant mainly contains monoterpenes and sesquiterpenes. According to this literature survey, it also appears that up to now the chemical composition of D. viscosa from Reunion Island, has not been investigated.
Stimulated by the numerous pharmacological actions of Dodonea viscosa and in order to contribute to a better knowledge of this species growing on Reunion Island under several morphotypes, a detailed GC-MS examination of the leaf essential oil of Dodonea viscosa belonging to the group of morphotype 2 was undertaken. The present study deals with the isolation and structure elucidation of three modified cyclopropylclerodanes containing a bicyclo[5.4.0]undecane nucleus and present in high amount in the essential oil: one new furanoid norditerpene, dodovisate C (1), and two furanoid diterpenes, the known methyl dodovisate A (2) and the new methyl iso-dodovisate A (3). (Figure 1).

2. Results and Discussion

This section is divided into two parts. The first one, is devoted to the detailed analysis of the essential oil by GC-MS. The second one describes the isolation and identification by means of 1D and 2D NMR spectroscopy of the three oxygenated compounds, one nor-diterpene (dodovisate C (1)) and two diterpenes (methyl dodovisate A (2) and methyl iso-dodovisate A (3)) present in high amounts in the essential oil. In this part, computational studies applied to dodovisate C in order to determine its absolute configuration, and to methyl dodovisate A and methyl iso-dodovisate A in order to determine their relative configuration, are described.

2.1. Essential Oil Composition

The essential oil obtained by hydrodistillation of the leaves of D. viscosa, exhibited a pale yellow to yellow-green colour, a strong odour and a partially solid consistency. The oil yield, calculated from fresh material, was 0.10%. The chromatographic analyses (GC-MS) of the essential oil sample allowed the detection of more than 80 compounds accounting for 80.5% of the total oil composition. Their retention indices and their composition are listed in Table 1. All the constituents grouped by chemical classes are arranged according to their elution order on the SPB-5 column.
The essential oil composition was characterized by a high amount of oxygenated nor-diterpenes and diterpenes (51.5%). The biggest contribution to the oxygenated nor-diterpenes and diterpenes fraction was given by three components (13) that could not be identified by computer matching with MS libraries (laboratory made and commercial) and linear retention indices. Although quantitatively lower, the aromatic compounds were clearly present: 30 compounds accounting for 12.9% of the oil. Most of them were detected in trace amount (<0.1%).
The GC-MS result obtained in this study was significantly different from the previous published results on the leaf essential oil of Dodonea viscosa from the southern mountain region of Western Saudi Arabia [64]. The chemical constituents of this essential oil were reported to be four monoterpene hydrocarbons, two monoterpene alcohols (traces), five sesquiterpene hydrocarbons of which cis-caryophyllene was the major constituents, and three sesquiterpene alcohols (guaiol, β-eudesmol and a third unidentified compound).

2.2. Terpenoids Isolation and Identification

Repeated chromatographic purification (silica gel flash column and reverse phase-HPLC) of the essential oil of Dodonea viscosa, led to the isolation of pure compounds 13.
A molecular formula C19H24O suggesting that 1 is an oxygenated nor-diterpene with eight degrees of unsaturation, was determined through HRESIMS (m/z [M + H]+ 269.1526, calcd 269.1905) and NMR data (Table 2). The HSQC and HMBC spectra (Table 2) revealed the presence of the following substructures: (a) a beta substituted furane ring (δC 110.0, 124.9, 137.3, 141.5), (b) a cycloheptatriene (CHT) moiety (δC 33.8, 123.2, 124.7, 128.0, 130.9, 131.1, 134.0) as well as (c) two methyl groups (δC 15.1, 22.0). Assembling the above substructures was mainly deduced from CH-correlations (Figure 2); that is, the furane was connected to the quaternary sp3 C-8 carbon atom carrying the singlet methyl C-19 via an ethylene bridge. Furthermore, C-8 was placed next to the CHT ring which was shown to be condensed to a methylcyclohexane ring. In addition, the furylethyl moiety was confirmed by EIMS fragments i.e., m/z 81 (furylmethylene fragment) as well as m/z 95 and m/z 173 (M-95) (furylethylene fragment). The above connectivities completed the gross structure of the molecule.
The relative stereochemistry of 1, due to the twisted cyclohexene ring, making the NOE correlations ambiguous, could not be established. A computational study was therefore undertaken on its 8R, 9S and 8R, 9R isomers. Purposes of this density functional study were 1) to determine the relative configuration of dodovisate C through a comparison between calculated (for isomers 8R, 9S and 8R, 9R) and experimental 13C chemical shifts; 2) to elucidate the absolute stereochemistry of 1 via a comparison between experimental and calculated electronic circular dichroism spectra (ECD). As dodovisate C is a flexible molecule, its conformational analysis was therefore a prerequisite to the calculation of its ECD and NMR spectra. For the first task, geometries of the 8R, 9S and 8R, 9R isomers were optimized at the B3LYP/6-311+G(d,p) level. For each isomer, 12 conformations were optimized. The 12 figures of 8R, 9S (resp. 8R, 9R) conformers, their energies, dipole moments, relative energies and populations at 25 °C were gathered in Table 3 (resp. Table 4). Among them, there were two opposite boat conformations of the CHT ring, three different conformations of the furan ring (defined by the C13-C14-C15-C18 dihedral angle in Table 3 and Table 4) and two different twisted conformations of the cyclohexene ring leading to (2 × 3 × 2) = 12 conformers. All the conformers (g–l and g’–l’) with methyl group on C-9 in axial position were found to be more than 11.9 kJ/mol higher in energy than the most stable conformer of each isomer (a for 8R, 9S and f’ for 8R, 9R). Therefore, according to Boltzmann statistics, populations of g–l and g’–l’ conformers were almost zero at 25 °C. Among the other 12 conformers a-f and a’-f’ with equatorial methyl group on C-9, conformers a-c and a’–c’ (resp. d–f, d’–f’) shared the same boat conformations of CHT ring.
13C NMR spectra of all conformers (with population > 0.1%) were calculated for each isomer at B3LYP/6-311+G(d,p) level. Then, calculated NMR chemical shifts were balanced thanks to Boltzmann statistics. Boltzmann-weighted chemical shifts versus experimental ones were plotted in Figure 3. The calculated 13C chemical shifts of 8R, 9S isomer clearly showed a better correlation to experiment than those of 8R, 9R isomer: the standard error of the fit s(8R, 9S) = 1.4 ppm was lower than s(8R, 9R) = 2.2 ppm; the Fisher F-statistic of isomer 8R, 9S was more than double of that of isomer 8R, 9R; standard errors on the slope, the intercept and the correlation coefficient were always lower for 8R, 9S isomer than for the 8R, 9R one’s. In a not surprising way, the calculated C-9R chemical shift had the largest deviation to experiment. In conclusion, the correlation of calculated versus experimental NMR chemical shifts clearly distinguished the 8S*, 9R* relative configuration from 8R*, 9R* one’s. A joint experimental and theoretical study using polarized light was carried out to assign the absolute configuration of dodovisate C. The experimental ECD spectrum of 1 is shown in Figure 4. In this spectrum, wavelengths of extreme values of Cotton effect were positive around 300 and 220 nm, negative around 260 nm. ECD spectra of the six populated conformers of 8R, 9S isomer were calculated at TD-B3LYP/6-311+G(d,p) level. Then, a Boltzmann-weighted calculated ECD spectrum was computed to allow comparison to experiment. In Figure 5, Boltzmann-weighted calculated ECD spectrum of 8R, 9S and 8S, 9R enantiomers were drawn. The comparison of calculated and experimental ECD spectra showed that the absolute configuration of dodovisate C isolated from the essential oil of Dodonea viscosa leaves was found to be 8S, 9R. For this enantiomer, calculated wavelengths of the positive (298 and 219 nm) and negative (259 nm) Cotton effects were in good agreement with experiment. The minimum energy DFT structure of this compound was shown in Figure 6. It had the same properties (energy, dipole moment, …) as conformer a in Table 3.
The second closely related isolated compound (2) displayed a m/z [M + H]+ peak at 327.1942 (calcd 327.1960) in the HRESIMS, consistent with a molecular formula of C21H26O3 and suggesting the occurrence of nine degrees of unsaturation. This formula was fully supported by NMR data (Table 2). Compound 2 was found to be identical in structure to 1 except for the carbomethoxyl moiety on the CHT ring. NMR data evidenced for 2, a CHT ring like dodovisate C (1). But additionally, 2 carries a methyl ester at C-3, the required ninth double bond equivalent. The presence of the carbomethoxy group was suggested by the carbon resonances at δ 166.9 (s) and 51.9 (q), and it was confirmed by the HSQC correlation of the latter resonance to the three-proton resonance at δ 3.78 (s). Finally, compound 2 was found to be methyl dodovisate A, a modified clerodane previously isolated from same plant Dodonea viscosa by Nui et al. [60] As for dodovisate C (1), absence of NOE correlations prevented determination of the absolute configuration of methyl dodovisate A (2). Computational study was undertaken on methyl dodovisate A 8R, 9S and 8R, 9R isomers. Geometries of the 8R, 9S and 8R, 9R isomers were optimized exactly like dodovisate C. 12 conformations were optimized with methyl group on C-9 in equatorial position. The 12 figures of 8R, 9S (resp. 8R, 9R) conformers, their energies, dipole moments, relative energies, and populations at 25 °C were gathered in Table 5 and Table 6. The carbomethoxy group has two distinct positions. 13C-NMR spectra of all conformers (with population > 0.1%) were calculated for each isomer at B3LYP/6-311+G(d,p) level. Calculated NMR chemical shifts were weighted thanks to Boltzmann statistics. The calculated 13C chemical shifts of 8R, 9S isomer clearly showed a better correlation to experiment than those of 8R, 9R isomer: the standard error of the fit s(8R, 9S) = 1.7 ppm was lower than s(8R, 9R) = 2.1 ppm; the Fisher F-statistic of isomer 8R, 9S (F = 18342) is more important than that of isomer 8R, 9R (F = 11412); standard errors on the slope, the intercept and the correlation coefficient were presented in Table 7. Methyl dodovisate A (2) is suggested to be the isomer 8R*, 9S* or the isomer 8S*, 9R*.
Methyl iso-dodovisate A (3) was found to be an isomer of 2, showing the same molecular formula C21H26O3. The 1H and 13C-NMR spectra of 3 were very similar to those of 2, the only difference being the location of the three double bonds in the CHT ring. The structure of 3 (the 2,4,6-triene isomer) was achieved from the many HMBC correlations cross peaks (Table 2). The relative stereochemistry of the three chiral centers (C-1, C-8 and C-9) was deduced from the following NOE correlations, i.e., if H-1 is on one side of the bicyclic system the two methyl groups (Me-19 and Me-20) are on the opposite side. The key NOEs are from methyl 19 (δ 0.72) to H-2 (δ 6.31), H-6 (δ 6.13) and one of the H-10 (δ 1.54 m) protons establishing the twisting of the two rings (see Dreiding model). An NOE from methyl 19 to methyl 20 determined the latter two to be on the same side of the molecule. In this case the different twisting of the cyclohexane ring enabled to see the NOE between the two methyls (Figure 7). Computational study was performed on methyl iso-dodovisate A (3) for which, the carbon atoms 1, 8 and 9 are chiral. Geometries of the 1S, 8R, 9R (12 conformers with methyl group on C-9 in equatorial position); 1S, 8R, 9S (9 conformers with methyl group on C-9 in equatorial position); 1S, 8S, 9R (12 conformers with methyl group on C-9 in equatorial position) and 1S, 8S, 9S (7 conformers with methyl group on C-9 in equatorial position) isomers were optimized. The minimum energy DFT structure of this compound was shown in Table 8, Table 9, Table 10 and Table 11. There are two conformations of the CHT ring, one almost coplanar and the other one deeper in energy which represents a twisted cycle. Three different conformations of the furan ring defined by the C13-C14-C15-C18 dihedral angle exist, the carbomethoxy group has distinct orientations. The hexan 6 membered ring possesses two forms associated to the twisted CHT ring, the first one is in a boat-like form and the second one is in an envelope-like form. 13C-NMR spectra of all conformers (with population > 0.1%) were calculated for each isomer at B3LYP/6-311+G(d,p) level. Calculated NMR chemical shifts were weighted thanks to Boltzmann statistics. The calculated 13C chemical shifts of 1S, 8R, 9R isomer clearly showed a better correlation to experiment than the other three isomers: the standard error of the fit s(1S, 8R, 9R) = 1.7 ppm was the lowest; the Fisher F-statistic of isomer 1S, 8R, 9R (F = 15132) is the more important factor; standard errors on the slope, the intercept and the correlation coefficient were presented in Table 7. Methyl iso-dodovisate A (3) is suggested to be the isomer 1S*, 8R*, 9R* or the isomer 1R*, 8S*, 9S*.

2.3. Discussion

No previous report on essential oils has described the presence of natural clerodanes whose decaline nucleus has been modified to a bicyclo[5.4.0]undecane, like dodovisate C (1), methyl dodovisate A (2) and methyl iso-dodovisate A (3). However, such bicyclic diterpenes have already been isolated from the organic extracts of a small number of species among which Conyza scabrida [65], several Portulaca species [66,67,68], Baccharis linearis [69], and Dodonea viscosa [63].

3. Materials and Methods

3.1. General Experimental Procedure

All solvents were HPLC or analytical grade. Silica gel 60 (particle size 63–200 µm, Machery-Nagel, Höerdt, France) was used for column chromatography. HPLC separations were performed on a LiChrospher RP-18 column (5 µm, 250 × 4 mm i.d., Merck, Darmstadt, Germany) with a Waters 600 pump coupled to a Waters 486 UV/Vis detector. Chromatographic data were collected and processed using the Empower software (Version 1, Waters, Milford, MA, USA). Optical rotation was determined on a Jasco P-1010 polarimeter (Tokyo, Japan) using a sodium lamp operating at 589 nm. ECD spectrum of 1 was measured at 25 °C in methanol at c = 4.85 × 10−4 mol·L−1 on a JASCO J-810 circular dichroism spectrometer (Tokyo, Japan). NMR spectra including NOESY, HMBC and HSQC experiments were recorded in CDCl3 on a Bruker Avance-600 spectrometer or on a Bruker Avance-500 spectrometer (Wissenbourg, France) operating at 600 and 500 MHz (1H) and 150 and 125 MHz (13C) respectively, with chemical shifts reported in ppm (δ) relative to TMS as internal standard. GC analyses were performed on a Varian Gas chromatograph Model CP-3800 (Walnut Creek, CA, USA), equipped with a flame ionization detection (FID) system (Walnut Creek, CA, USA) and a non-polar SPB-5 capillary column (60 m × 0.32 mm I.D., film thickness 0.25 µm, Bellefonte, USA). The oven temperature was programmed from 60 °C to 230 °C at 4 °C/min and then held isothermally at 230 °C for 40 min. Injector and detector temperatures were maintained at 250 °C and 300 °C, respectively. Nitrogen was used as the carrier gas at a flow rate of 0.7 mL/min. The samples diluted in CH2Cl2 were injected in splitless mode. GC-MS analyses (Palo Atto, CA, USA) were carried out using a Hewlett-Packard chromatograph type 6890 series equipped with a SPB-5 column (60 m × 0.32 mm i.d., film thickness 0.25 µm) and coupled to a HP 5972 mass selective detector. The MS detector was used in the EI mode with an ionization voltage of 70 eV over the m/z range 30–550. The carrier gas was Helium at a flow rate of 0.7 mL/min. The oven temperature was programmed from 60 °C to 230 °C at a rate of 4 °C/min, held for 40 min. The injector and the transfer line were both programmed to 250 °C. The samples diluted in CH2Cl2 were injected using a 20:1 split ratio.

3.2. Plant Material

The voucher number, the place and date of collection of Dodonea viscosa are given in Table 12. The specimen was identified by H. Thomas and deposited with the herbarium of Reunion Island (REU).

3.3. Essential oil Extraction

Fresh leaves were hydrodistilled in a Clevenger-type apparatus for 3 h. The oil was taken up in dichloromethane, dried over anhydrous sodium sulphate and kept at 4 °C. The extraction yield is reported in Table 12.

3.4. Isolation and Purification of Dodovisate C (1), methyl dodovisate A (2) and methyl iso-dodovisate A (3)

The essential oil (988.0 mg) was chromatographed on a silica gel flash column eluted successively with iso-hexane (150 mL) and EtOAc (150 mL). The iso-hexane fraction (33.9 mg) containing dodovisate C (1), was then further submitted to RP-HPLC purification using a gradient of elution (20% CH3CN-H2O to 100% CH3CN over 30 min, then maintained at 100% CH3CN for 10 min) and a flow rate of 1.0 mL/min, to afford 5.2 mg of 1 (colorless, amorphous solid).
The essential oil (86.0 mg) was chromatographed on a silica gel flash column eluted successively with iso-hexane (150 mL) and EtOAc (150 mL). The EtOAc fraction (22.9 mg) containing methyl dodovisate A (2) and methyl iso-dodovisate A (3), was then further submitted to repeated column chromatography over flash silica gel with n-hexane–EtOAc gradient to afford 13.9 mg of 2 and 1.3 mg of 3 (light yellowish oils with a strong aromatic odours). The fractions were monitored by GC-MS.

3.5. Identification and Quantification

The identification of individual components was based on: (a) comparison of calculated linear retention indices (LRIs), on apolar columns with those of literature data [70,71,72]; (b) computer matching with commercial mass spectral libraries (NIST and Wiley) and comparison of mass spectra with those of our laboratory-built library or literature data [70,71]; (c) 1D- (1H, 13C, APT) and 2D-(HSQC, HMBC, NOESY) NMR spectra only for dodovisate C (1), methyl dodovisate A (2) and methyl iso-dodovisate A (3) after isolation and purification. The quantification of the components was performed on the basis of their GC peak areas on the SPB-5 column without FID response factor correction.
Dodovisate C (8-(2-furanethyl)-8,9-dimethylbicyclo[5.4.0]undeca-1,3,5-triene, 1): Colorless amorphous solid: [ α ] D 20 +4.85 (c 0.21, 23 °C, CH2Cl2); EI-MS 70 eV, m/z (rel. int.): 268 [M+] (17), 253(3), 240(8), 173(100), 159(13), 145(24), 131(74), 117(66), 104(37), 91(35), 81(26), 69(9), 53(12), 41(14); NMR spectral data: see Table 2.
Methyl dodovisate A (3-acetoxy-8-(2-furanethyl)-8,9-dimethylbicyclo[5.4.0]undeca-1,3,5-triene, 2): Yellowish oil: EI-MS 70 eV m/z (rel. int.): 326 [M]+ (18), 311 [M − CH3]+ (5), 295 [M − CH3 −H2O]+ (4), 267 (7), 231 (100), 217 (9), 199 (28), 189 (16), 175 (28), 163 (35), 157 (21), 149 (18), 129 (27), 128 (27), 115(19), 105 (9), 95 (19), 81 (25), 69 (17), 59 (9), 41 (9); NMR spectral data: see Table 2.
Methyl iso-dodovisate A (3-acetoxy-8-(2-furanethyl)-8,9-dimethylbicyclo[5.4.0]undeca-2,4,6-triene, 3): Yellowish oil: EI-MS 70 eV m/z (rel. int.): 326 [M]+ (18), 311 [M − CH3]+ (5), 295 [M − CH3 −H2O]+ (4), 267 (7), 231 (100), 217 (9), 199 (28), 189 (16), 175 (28), 163 (35), 157 (21), 149 (18), 129 (27), 128 (27), 115(19), 105 (9), 95 (19), 81 (25), 69 (17), 59 (9), 41 (9); NMR spectral data: see Table 2.
The compounds NMR and MS data of compounds 1 and 3 can be found in the Supplementary Information.

3.6. Computational Details

All DFT calculations were carried out using the GAUSSIAN 09 program [73] using the hybrid B3LYP exchange-correlation functional [74,75] and the 6-311+G(d,p) basis set. Tight convergence criteria were used for geometry optimization. All stationary points were confirmed as true minima via vibrational frequency calculations. Frequencies calculated in the harmonic approximation were multiplied with a factor set to 0.98.
NMR shielding tensors were computed with the Gauge-Independent Atomic Orbital (GIAO) method [76]. The calculated nuclear isotropic magnetic shieldings (IMS) were converted for carbons C–i into chemical shifts by referencing to tetramethylsilane (TMS) IMS calculated at the same level of theory (IMSTMS = 184.1416 ppm): δcorr = IMSTMS − IMSC–i.
Electronic excitation energies and rotational strengths for all conformations have been calculated using the TDDFT methodogy of Gaussian 09 for the 150 lowest singlet vertical excitation energies at ground-state equilibrium geometries. Thence ECD spectra were obtained assuming the Condon approximation and the computed velocity rotatory strengths are transformed into units of Δε and superimposed with Gaussian functions centered at the respective wavenumbers of the electronic transitions. An exponential half-width at 1/e peak height Δσ = 0.4 eV was used for each gaussian curve [77].
Molecular structures were done with Molden software [78].

Supplementary Materials

The following are available online: Figure S1-S11: NMR data of 1. Figure S12: (+)HRESIMS spectrum of 1. Figure S13: EI-MS spectrum of 1. Figure S14: 1H NMR spectrum of 3. Figure S15: (+)HRESIMS spectrum of 3. Figure S16: EI-MS spectrum of 3.

Author Contributions

Conceptualization, A.G.-B.; methodology, A.G.-B., B.I. and A.M.; validation, A.G.-B., B.I., A.M. and J.S. (Jacqueline Smadja); investigation, A.G.-B., B.I., A.M., E.G., H.T., J.S. (Jonathan Sorres) and Y.K.; data curation, A.G.-B.; writing—original draft preparation, A.G.-B., B.I., A.M., J.S. (Jacqueline Smadja); writing—review and editing, A.G.-B., A.M.; supervision, A.G.-B.; project administration, J.S. (Jacqueline Smadja). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shanmugavasan, A.; Ramachandran, T. Investigation of the extraction process and phytochemical composition of preparations of Dodonea viscosa (L.) Jacq. J. Ethnopharmacol. 2011, 137, 1172–1176. [Google Scholar] [CrossRef] [PubMed]
  2. Abbasi, A.M.; Khan, M.A.; Ahmad, M.; Zafar, M.; Jahan, S.; Sultana, S. Ethnopharmacological application of medicinal plants to cure skin diseases and in folk cosmetics among the tribal communities of north-west frontier povince, Pakistan. J. Ethnopharmacol. 2010, 128, 322–335. [Google Scholar] [CrossRef] [PubMed]
  3. Desta, B. Ethiopian traditional herbal drugs. Part I: Studies on the toxicity and therapeutic activity of local taenicidal medications. J. Ethnopharmacol. 1995, 45, 27–33. [Google Scholar] [PubMed]
  4. Giday, M.; Teklehaymanot, T.; Animut, A.; Mekonnen, Y. Medicinal plants of the Shinasha, Age-awi and Amhara peoples in northwest Ethiopia. J. Ethnopharmacol. 2007, 110, 516–525. [Google Scholar] [CrossRef]
  5. Chhabra, S.C.; Mahunnah, R.L.; Mshiu, E.N. Plants used in traditional medicine in eastern Tanzania. V. Angiosperms (Passifloraceae to Sapindaceae). J. Ethnopharmacol. 1991, 33, 143–157. [Google Scholar] [CrossRef]
  6. De Beer, J.J.J.; Van Wyk, B.E. An ethnobotanical survey of the Agter–Hantam, Northern Cape Province, South Africa. South Afr. J. Bot. 2011, 77, 741–754. [Google Scholar] [CrossRef] [Green Version]
  7. McGaw, L.J.; Lall, N.; Meyer, J.J.M.; Eloff, J.N. The potential of South African plants against Mycobacterium infections. J. Ethnopharmacol. 2008, 119, 482–500. [Google Scholar] [CrossRef]
  8. Thring, T.S.A.; Weitz, F.M. Medicinal plant use in the Bredasdorp/Elim region of the Southern Overberg in the Western Cape Province of South Africa. J. Ethnopharmacol. 2006, 103, 261–275. [Google Scholar] [CrossRef]
  9. van Wyk, B.E. A review of Khoi-San and Cape Dutch medical ethnobotany. J. Ethnopharmacol. 2008, 119, 331–341. [Google Scholar] [CrossRef]
  10. van Wyk, B.E. The potential of South African plants in the development of new medicinal products. South Afr. J. Bot. 2011, 77, 812–829. [Google Scholar] [CrossRef] [Green Version]
  11. Lavergne, R. Fleurs de Bourbon; Cazal Publishing: Sainte-Clotilde, France, 1984; p. 199. [Google Scholar]
  12. Tene, V.; Malagón, O.; Finzi, P.V.; Vidari, G.; Armijos, C.; Zaragoza, T. An ethnobotanical survey of medicinal plants used in Loja and Zamora-Chinchipe, Ecuador. J. Ethnopharmacol. 2007, 111, 63–81. [Google Scholar] [CrossRef] [PubMed]
  13. Colodel, E.M.; Traverso, S.D.; Seitz, A.L.; Correa, A.; Oliveira, F.N.; Driemeier, D.; Gava, A. Spontaneous poisoning by Dodonea viscosa (Sapindaceae) in cattle. Vet. Hum. Toxicol. 2003, 45, 147–148. [Google Scholar] [PubMed]
  14. Mata, R.; Contreras, J.L.; Crisanto, D.; Pereda-Miranda, R.; Castañeda, P.; Del Rio, F. Chemical studies on mexican plants used in traditional medicine. XVIII. New secondary metabolites from Dodonea viscosa. J. Nat. Prod. 1991, 54, 913–917. [Google Scholar]
  15. Rojas, A.; Cruz, S.; Ponce-Monter, H.; Mata, R. Smooth muscle relaxing compounds from Dodonea viscosa. Planta Med. 1996, 62, 154–159. [Google Scholar] [CrossRef]
  16. Rasoanaivo, P.; Petitjean, A.; Ratsimamanga-Urverg, S.; Rakoto-Ratsimamanga, A. Medicinal plants used to treat malaria in Madagascar. J. Ethnopharmacol. 1992, 37, 117–127. [Google Scholar] [CrossRef]
  17. Gurib-Fakim, A.; Gueho, J. Plantes Médicinales de Maurice; Océan Indien Publishing: Rose-Hill, Maurice, 1997; Volume 3, p. 253. [Google Scholar]
  18. Gurib-Fakim, A. Plantes médicinales de Maurice et d’ailleurs; Graphic Press Ltd. Publishing: Baie du Tombeau, Maurice, 2007; p. 68. [Google Scholar]
  19. Gurib-Fakim, A.; Gueho, J. Plantes Médicinales de l’île Rodrigues; Océan Indien Publishing: Rose-Hill, Maurice, 1994; p. 447. [Google Scholar]
  20. de Cordemoy, E.J. Flore de l’Ile de la Réunion (1895); Kessinger Publishing: Paris, France, 2010; p. 381. [Google Scholar]
  21. Lavergne, R. Tisaneurs et plantes médicinales indigènes; Orphie Publishing: Paris, France, 1990; p. 258. [Google Scholar]
  22. Lavergne, R. Les plantes médicinales du Père Raimbault; Azalées Publishing: La Réunion, France, 2000; p. 81. [Google Scholar]
  23. Lucas, R. Cent plantes endémiques et indigènes de La Réunion; Azalées Publishing: La Réunion, France, 2007; p. 69. [Google Scholar]
  24. Père Nantas. Le père Raimbault et les plantes médicinales de La Réunion; Nouvelle imprimerie Dionysienne Publishing: La Réunion, France, 1984; p. 35. [Google Scholar]
  25. Rivière, M. Les plantes médicinales à l’île de La Réunion, leurs amis et leurs faux amis; Azalées Publishing: La Réunion, France, 2007; p. 18. [Google Scholar]
  26. Giraud-Técher, S.; Amédée, J.; Girard-Valenciennes, E.; Thomas, H.; Brillant, S.; Grondin, I.; Marodon, C.; Smadja, J. Plantes médicinales de La Réunion inscrites à la Pharmacopée française. Ethnopharmacologia 2016, 56, 7–33. [Google Scholar]
  27. Smadja, J.; Marodon, C.; Amedee, J.; Brillant, S.; Hermann, T. Plantes médicinales de l’île de La Réunion inscrites à la Pharmacopée Française; Orphie Publishing: La Réunion, France, 2016; p. 49. [Google Scholar]
  28. Rojas, A.; Hernandez, L.; Pereda-Miranda, R.; Mata, R. Screening for antimicrobial activity of crude drug extracts and pure natural products from Mexican medicinal plants. J. Ethnopharmacol. 1992, 35, 275–283. [Google Scholar] [CrossRef]
  29. Adsersen, A.; Adsersen, H. Plants from Réunion island with alleged antihypertensive and diuretic effects—An experimental and ethnobotanical evaluation. J. Ethnopharmacol. 1997, 58, 189–206. [Google Scholar] [CrossRef]
  30. Motsei, M.L.; Lindsey, K.L.; van Staden, J.; Jäger, A.K. Screening of traditionally used south african plants for antifungal activity against Candida albicans. J. Ethnopharmacol. 2003, 86, 235–241. [Google Scholar] [CrossRef]
  31. Getie, M.; Gebre-Mariam, T.; Rietz, R.; Höhne, C.; Huschka, C.; Schmidtke, M.; Abate, A.; Neubert, R.H.H. Evaluation of the anti-microbial and anti-inflammatory activities of the medicinal plants Dodonea viscosa, Rumex nervosus and Rumex abyssinicus. Fitoterapia 2003, 74, 139–143. [Google Scholar] [CrossRef]
  32. Clarkson, C.; Maharaj, V.J.; Crouch, N.R.; Grace, O.M.; Pillay, P.; Matsabisa, M.G.; Bhagwandin, N.; Smith, P.J.; Folb, P.I. In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. J. Ethnopharmacol. 2004, 92, 177–191. [Google Scholar] [CrossRef] [PubMed]
  33. Poullain, C.; Girard-Valenciennes, E.; Smadja, J. Plants from Reunion island: Evaluation of their free radical scavenging and antioxidant activities. J. Ethnopharmacol. 2004, 95, 19–26. [Google Scholar] [CrossRef] [PubMed]
  34. Khalil, N.M.; Speretto, J.S.; Manfron, M.P. Antiinflammatory activity and acute toxicity of Dodonea viscosa. Fitoterapia 2006, 77, 478–480. [Google Scholar] [CrossRef] [PubMed]
  35. Desrivot, J.; Waikedre, J.; Cabalion, P.; Herrenknecht, C.; Bories, C.; Hocquemiller, R.; Fournet, A. Antiparasitic activity of some New Caledonian medicinal plants. J. Ethnopharmacol. 2007, 112, 7–12. [Google Scholar] [CrossRef]
  36. Patel, M.; Coogan, M.M. Antifungal activity of the plant Dodonea viscosa var. angustifolia on Candida albicans from HIV-infected patients. J. Ethnopharmacol. 2008, 118, 173. [Google Scholar]
  37. Pengelly, A. Medicinal activity of Dodonea viscosa—A preliminary study. In Rural Industries Research and Development Corporation; Australian Government publishing: Canberra, Australia, 2008. [Google Scholar]
  38. Venkatesh, S.; Reddy, Y.S.R.; Ramesh, M.; Swamy, M.M.; Mahadevan, N.; Suresh, B. Pharmacognosy studies on Dodonea viscosa leaves. Afr. Pharm. Pharmacol. 2008, 24, 83–88. [Google Scholar]
  39. Arun, M.; Asha, V.V. Gastroprotective effect of Dodonea viscosa on various experimental ulcer models. J. Ethnopharmacol. 2008, 118, 460–465. [Google Scholar] [CrossRef]
  40. Cao, S.; Brodie, P.; Callmander, M.; Randrianaivo, R.; Razafitsalama, J.; Rakotobe, E.; Rasamison, V.E.; TenDyke, K.; Shen, Y.; Suh, E.M.; et al. Antiproliferative triterpenoid saponins of Dodonea viscosa from the Madagascar dry forest. J. Nat. Prod. 2009, 72, 1705–1707. [Google Scholar] [CrossRef] [Green Version]
  41. Teffo, L.S.; Aderogba, M.A.; Eloff, J.N. Antibacterial and antioxidant activities of four kaempferol methyl ethers isolated from Dodonea viscosa Jacq. var angustifolia leaf extracts. South Afr. J. Bot. 2010, 76, 25–29. [Google Scholar] [CrossRef] [Green Version]
  42. Jangra, M.; Sharma, S.; Kumar, M. Evaluation of antihyperglycemic activity of Dodonea viscosa leaves in normal and STZ-diabetic rats. Int. J. Pharm. Pharm. Sci. 2011, 3, 69–74. [Google Scholar]
  43. Ahmad, M.; Mahmood, Q.; Gulzar, K.; Aktar, M.S.; Saleem, M.; Qadir, M.I. Antihyperlipidemic and hepatoprotective activity of Dodonaea viscosa leaves extracts in alloxan-induced diabetic rabbits (Oryctolagus cuniculus). Pak. Vet. J. 2011, 32, 50–54. [Google Scholar]
  44. Muhammad, A.; Tel-Çayan, G.; Öztürk, M.; Duru, M.E.; Nadeem, S.; Anis, I.; Weng Ng, S.; Shah, M.R. Phytochemicals from Dodonaea viscosa and their antioxidant and anticholinesterase activities with structure–activity relationships. Pharm. Biol. 2016, 54, 1649–1655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Rao, K.V. Chemical examination of the leaves of Dodonea viscosa Linn. J. Indian Chem. Soc. 1962, 39, 561–562. [Google Scholar]
  46. Paris, R.; Nothis, A. Plantes de Nouvelle-Calédonie. II. Etude particulière de plantes à dérivés polyphénoliques. In Plantes Médicinales et Phytothérapie; Jouve Publishing: Paris, France, 1970; pp. 63–74. [Google Scholar]
  47. Hsü, H.Y.; Chen, Y.P.; Kakisawa, H. Structure of hautriwaic acid. Phytochemistry 1971, 10, 2813–2814. [Google Scholar] [CrossRef]
  48. Ramachandran Nair, A.G.; Sankara Subramanian, S. Isorhamnetin & quercetin glycosides from Dodonea viscosa & Sapindus emarginatus. Indian J. Chem. 1975, 13, 639–640. [Google Scholar]
  49. Dreyer, D.L. Kaempferol methyl ethers from flowers of Dodonea viscosa. Rev. Latinoam. Quimica 1978, 9, 97–98. [Google Scholar]
  50. Dominguez, X.A.; Franco, R.; Cano, C.G.; Chavez, C.N. Aislamiento de 3,6,4′-trimethoxi-5,7-dioxiflavona en el chapuliztle (Dodonea viscosa var. angustifolia Jacq) (Sapindaceae). Rev. Latinoamer. Quim. 1980, 11, 150–151. [Google Scholar]
  51. Sachdev, K.; Kulshreshtha, D.K. Aliarin, a new flavonoid from Dodonea viscosa Linn. Indian J. Chem. 1982, 21, 798–799. [Google Scholar]
  52. Sachdev, K.; Kulshreshtha, D.K. Flavonoids from Dodonea viscosa. Phytochemistry 1983, 22, 1253–1256. [Google Scholar] [CrossRef]
  53. Sachdev, K.; Kulshreshtha, D.K. Dodonic acid, a new diterpenoid from Dodonea viscosa. Planta Med. 1984, 50, 448–449. [Google Scholar] [CrossRef]
  54. Dimbi, M.Z.; Kapundu, M.; Darimont, E.; Warin, R.; Delaude, C.; Huls, R. Triterpénoïdes de Dodonea viscosa. Bull. Soc. Chim. Belg. 1985, 94, 141–148. [Google Scholar] [CrossRef]
  55. Sachdev, K.; Kulshreshtha, D.K. Viscosol, a C-3′ prenylated flavonoid from Dodonea viscosa. Phytochemistry 1986, 25, 1967–1969. [Google Scholar] [CrossRef]
  56. Ahmad, V.U.; Fatima, I.; Fatima, A. The sapogenins from Dodonea viscosa. Fitoterapia 1987, LVIII, 361–366. [Google Scholar]
  57. Wagner, H.; Ludwig, C.; Grotjahn, L.; Khan, M.S.Y. Biologically active saponins from Dodonea viscosa. Phytochemistry 1987, 26, 697–701. [Google Scholar] [CrossRef]
  58. Khan, M.S.Y.; Javed, K.; Hasnain Khan, M. Constituents of the flowers of Dodonea viscosa. Fitoterapia 1992, 63, 83–84. [Google Scholar]
  59. Ortega, A.; Garcı́a, P.E.; Cárdenas, J.; Mancera, C.; Marquina, S.; del Carmen Garduño, M.L.; Maldonado, E. Methyl dodonates, a new type of diterpenes with a modified clerodane skeleton from Dodonea viscosa. Tetrahedron 2001, 57, 2981–2989. [Google Scholar] [CrossRef]
  60. Niu, H.M.; Zeng, D.Q.; Long, C.L.; Peng, Y.H.; Wang, Y.H.; Luo, J.F.; Wang, H.S.; Shi, Y.N.; Tang, G.H.; Zhao, F.W. Clerodane diterpenoids and prenylated flavonoids from Dodonaea viscosa. J. Asian. Nat. Prod. Res. 2010, 12, 7–14. [Google Scholar] [CrossRef]
  61. Gao, Y.; Fang, Y.-D.; Hai, P.; Wang, F.; Liu, J.-K. Isoprenylated flavonoids and clerodane diterpenoids from Dodonea viscosa. Nat. Prod. Bioprospect. 2013, 3, 250–255. [Google Scholar] [CrossRef] [Green Version]
  62. Al-Aamri, K.K.; Hossain, M.A. New prenylated flavonoids from the leaves of Dodonea viscosa native to sultanate of Oman. Pac. Sci. Rev. A Nat. Sci. Eng. 2016, 18, 53–61. [Google Scholar] [CrossRef] [Green Version]
  63. Zhang, L.-B.; Liao, H.-B.; Zhu, H.-Y.; Yu, M.-H.; Lei, C. Antiviral clerodane diterpenoids from Dodonea viscosa. Tetrahedron 2016, 72, 8036–8041. [Google Scholar] [CrossRef]
  64. Mekkawi, A.G.; Mossa, J.S. Essential oil of Dodonaea viscosa Jacq. Pharmazie 1981, 36, 517. [Google Scholar]
  65. Bohlmann, F.; Grenz, M.; Wegner, P.; Jakupovic, J. Clerodan-derivate und neuartige diterpene aus Conyza scabrida DC. Liebigs Ann. Chem. 1983, 11, 2008–2020. [Google Scholar] [CrossRef]
  66. Ohsaki, A.; Shibata, K.; Tokoroyama, T.; Kubota, T. Structure of Pilosanones A and B: Novel diterpenoids with a bicyclo[5.4.0]undecane skeleton from Portulaca pilosa L. J. Chem. Soc. Chem. Commun. 1987, 3, 151–153. [Google Scholar] [CrossRef]
  67. Ohsaki, A.; Kasetani, Y.; Asaka, Y.; Shibata, K.; Tokoroyama, T.; Kubota, T. Clerodane diterpenoids from the roots of Portulaca pilosa. Phytochemistry 1991, 30, 4075–4077. [Google Scholar] [CrossRef]
  68. Ohsaki, A.; Ohno, N.; Shibata, K.; Tokoroyama, T.; Kubota, T.; Hirotsu, K.; Higuchi, T. Minor diterpenoids from Portulaca cv Jewel. Phytochemistry 1988, 27, 2171–2173. [Google Scholar] [CrossRef]
  69. He, K.; Montenegro, G.; Hoffmann, J.J.; Timmermann, B.N. Diterpenoids from Baccharis linearis. Phytochemistry 1996, 41, 1123–1127. [Google Scholar] [CrossRef]
  70. Adams, R.P. Identification of Essential Oils Components by Gas Chromatography/Quadrupole Mass Spectroscopy; Allured: Carol Stream, IL, USA, 2001. [Google Scholar]
  71. Joulain, D.; Konig, W.A. The Atlas of Spectral Data of Sesquiterpene Hydrocarbons; EB-Verlag: Hamburg, Germany, 1998; Available online: https://0-pubs-acs-org.brum.beds.ac.uk/doi/abs/10.1021/np990755n (accessed on 27 December 2019).
  72. Kondjoyan, N.; Berdagué, J.L. A Compilation of Relative Retention Indices for the Analysis of Aromatic Compounds, 1st ed.; Laboratoire Flaveur: Theix, France, 1996. [Google Scholar]
  73. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09; Revision D. 01; Gaussian, Inc.: Oxford, UK, 2013. [Google Scholar]
  74. Becke, A.D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648–5652. [Google Scholar] [CrossRef] [Green Version]
  75. Stephens, P.J.; Devlin, F.J.; Chabalowski, C.F.; Frisch, M.J. Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J. Phys. Chem. 1994, 98, 11623–11627. [Google Scholar] [CrossRef]
  76. Cheeseman, J.R.; Trucks, G.W.; Keith, T.A.; Frisch, M.J. A comparison of models for calculating nuclear magnetic resonance shielding tensors. J. Chem. Phys. 1996, 104, 5497–5509. [Google Scholar] [CrossRef]
  77. Stephens, P.J.; Harada, N. ECD cotton effect approximated by the Gaussian curve and other methods. Chirality 2010, 22, 229–233. [Google Scholar] [CrossRef]
  78. Schaftenaar, G. Noordik Molden: A pre- and post-processing program for molecular and electronic structures. J. Comput. Aided Mol. Des. 2000, 14, 123–134. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of Dodonea viscosa essential oil and the isolated compounds are available from the authors.
Figure 1. Structure of the three cyclopropylclerodanes isolated from Dodonea viscosa.
Figure 1. Structure of the three cyclopropylclerodanes isolated from Dodonea viscosa.
Molecules 25 00850 g001
Figure 2. Selected HMBC correlations for compound (1).
Figure 2. Selected HMBC correlations for compound (1).
Molecules 25 00850 g002
Figure 3. Plot of Boltzmann-weighted calculated NMR δ13C of 8R, 9S and 8R, 9R isomers versus experimental NMR δ13C of dodovisate C (1). Statistics for the regression of calculated versus experimental chemical shifts for both isomers. The slope, the intercept, the correlation coefficient (r) are followed by their standard error on the last digit(s) in brackets. F is the Fisher F-statistic and s the standard error of the fit.
Figure 3. Plot of Boltzmann-weighted calculated NMR δ13C of 8R, 9S and 8R, 9R isomers versus experimental NMR δ13C of dodovisate C (1). Statistics for the regression of calculated versus experimental chemical shifts for both isomers. The slope, the intercept, the correlation coefficient (r) are followed by their standard error on the last digit(s) in brackets. F is the Fisher F-statistic and s the standard error of the fit.
Molecules 25 00850 g003
Figure 4. Experimental ECD spectrum of dodovisate C (1).
Figure 4. Experimental ECD spectrum of dodovisate C (1).
Molecules 25 00850 g004
Figure 5. Boltzmann-weighted calculated ECD spectra of 8R, 9S and 8S, 9R enantiomers of dodovisate C (1).
Figure 5. Boltzmann-weighted calculated ECD spectra of 8R, 9S and 8S, 9R enantiomers of dodovisate C (1).
Molecules 25 00850 g005
Figure 6. Minimum B3LYP/6-311+G(d,p) energy structure of 8-(2-furanethyl)-8S,9R-dimethylbicyclo[5.4.0]undeca-1,3,5-triene or dodovisate C (1) isolated from essential oil of Dodonea viscosa leaves.
Figure 6. Minimum B3LYP/6-311+G(d,p) energy structure of 8-(2-furanethyl)-8S,9R-dimethylbicyclo[5.4.0]undeca-1,3,5-triene or dodovisate C (1) isolated from essential oil of Dodonea viscosa leaves.
Molecules 25 00850 g006
Figure 7. Selected NOE correlations for compound 3.
Figure 7. Selected NOE correlations for compound 3.
Molecules 25 00850 g007
Table 1. Chemical composition of the essential oil of leaves from Dodonea viscosa.
Table 1. Chemical composition of the essential oil of leaves from Dodonea viscosa.
Compounds aRI b% c
Hydrocarbons
n-heneicosane2097tr
n-pentacosane2495tr
total tr
Alcohols
hex-3-enol (Z/E configuration n.i.)8530.8
hex-2-enol (Z/E configuration n.i.)861tr
n-hexanol8640.8
oct-1-en-3-ol978tr
n-octanol1069m (1.3)
n-decanol1271tr
total 2.9
Ketones
isophorone1125tr
1-phenylbut-2-enone13120.3
(Z)-jasmone1401tr
geranylacetone14520.2
(E)-β-ionone14900.2
6,10,14-trimethylpentadecan-2-one18431.1
total 1.8
Carboxylic acids
isovaleric acid826tr
2-methylbutanoic acid837tr
hexanoic acid9730.3
benzoic acid1159tr
octanoic acid1167tr
dodecanoic acid15590.2
tetradecanoic acid17590.7
hexadecanoic acid19632.4
total 3.6
Esters
isopentyl isovalerate11041.5
n-hexyl butanoate1190tr
n-hexyl 2-methylbutanoate12360.4
n-hexyl 3-methylbutanoate12392.3
total 4.2
Oxygenated monoterpenes
trans-linalool oxide (furanoid)10740.1
cis-linalool oxide (furanoid)1091tr
linalool11001.0
terpinen-4-ol11820.4
α-terpineol11950.3
nerol12300.2
geraniol1255tr
total 2.0
Sesquiterpene hydrocarbons
aromadendrene14490.2
(E,E)-α-farnesene1508tr
δ-cadinene1530tr
α-calacorene1551tr
total 0.2
Oxygenated sesquiterpenes
(E)-nerolidol15650.2
(Z)-dihydro-apofarnesol1579tr
spathulenol15880.5
globulol15950.5
viridiflorol16040.2
epi-α-muurolol1658tr
α-cadinol16640.2
(2E,6Z)-farnesol1744tr
total 1.6
Oxygenated diterpenes
isophytol1947tr
(1)203635.0
phytol21110.5
(2) + (3)2420m (16.0)
hardwickiic acid, methyl ester2431m (16.0)
total 51.5
Aromatic compounds
benzaldehyde9630.1
benzyl alcohol10351.8
benzene acetaldehyde10450.1
o-cresol10540.7
acetophenone1068m (1.3)
phenylethyl alcohol1116tr
methyl salicylate11990.5
4-vinyl phenol12180.1
chavicol1254tr
p-anisaldehyde dimethyl acetal1256tr
p-ethylacetophenone1285tr
1-phenylbut-2-en-1-one13120.3
2-methoxy-4-vinylphenol13170.5
benzyl butanoate1346tr
eugenol13600.9
methyl p-anisate1378tr
benzyl isovalerate13952.1
vanillin1401tr
methyl eugenol14030.4
2-methylbutyl benzoate14400.2
ethyl vanillin1461tr
phenylethyl 3-methylbutanoate14930.5
asaricin 1500tr
isopentyl salicylate15390.1
(3Z)-hexenyl benzoate15740.8
n-hexyl benzoate15801.0
(3Z)-hexenyl salicylate16730.2
n-hexyl salicylate16810.2
benzyl benzoate17710.6
benzyl salicylate18770.5
total 12.9
Others
7-methyl-1,6-dioxaspiro [4,5] decane (stereoisomer n.i.)10581.1
vitispirane1286tr
total 1.1
Total identified 80.5
a n.i.: Non identified; b LRI: Linear retention index calculated on non-polar (SPB-5) column; c Relative percentage based on the peak area from the GC-MS analysis; tr: trace (<0.1%).
Table 2. 1D and 2D NMR spectroscopic data for dodovisate C (1), methyl dodovisate A (2), methyl iso-dodovisate A (3).
Table 2. 1D and 2D NMR spectroscopic data for dodovisate C (1), methyl dodovisate A (2), methyl iso-dodovisate A (3).
PositionDodovisate C (1)Methyl Dodovisate A (2)Methyl Iso-Dodovisate A (3)
δ 13C
(150 MHz)
δ 1H
(600 MHz)
HMBC
(H→C)
δ 13C
(500 MHz)
δ 1H
(125 MHz)
HMBC
(H→C)
δ 13C
(500 MHz)
δ 1H
(125 MHz)
HMBC
(H→C)
1130.9 s 135.5 s 38.3 d1.52 m a2, 4, 6, 7, 10, 11
233.8 t2.28 dd (12.3, 7.0)
2.07 dd (12.3, 6.8)
1, 3, 4, 7, 1133.3 t2.30 m
2.71 bd (11.5)
1, 3, 4, 7135.0 d6.31 d (3.7)1, 4, 5w, 11
3123.2 d5.49 ddd (8.9, 7.0, 6.8)1, 2, 5123.7 s 126.8 s
4124.7 d5.98 dd (8.9, 5.1)2, 6132.0 d7.10 d (5.6)2, 3, 5, 6125.9 d7.06 d (11.1)2, 6
5128.0 d6.40 dd (11.4, 5.1)3, 4, 7127.6 d6.58 dd (11.6, 5.6)1, 3, 4131.5 d6.75 dd (11.1, 5.7)2 w, 4, 6, 7
6131.1 d6.64 d (11.4)1, 4, 5, 7, 8136.6 d6.97 d (11.6)3, 4, 5, 7, 8119.5 d6.13 d (5.7)4
7134.0 s 134.5 s 143.5 s
839.1 s 40.4 s 42.3 s
932.3 d1.69 m7, 8, 1933.2 d1.78 m1934.9 d1.89 m a19
1026.2 t1.40 m1, 8, 926.9 t1.45 m
1.55 m
1, 8, 926.3 t1.54 m a
1.73 m (dquin like)
1 w, 8, 11
1131.4 t2.16 m
2.34 m
1, 7, 1031.8 t2.28 m
2.43 m
1, 7, 1028.4 t1.78 m2.02 m1 w, 9, 10
12 166.9 s 167.6 s
1337.5 t1.69 m7, 8, 9, 14, 1538.3 t1.80 m8, 9, 1437.0 t1.83 m a, 1.89 ma
1418.4 t1.88 m
2.16 m
13, 15, 16, 1819.5 t1.97 m
2.23 m
13, 15, 16, 1819.6 t2.53 dbrt (3.8, 12.2)
2.43 dbrt (5.2, 12.2)
9 w, 13, 15, 16, 18
15124.9 s 125.6 s 125.6 s
16110.0 d6.18 s15, 17, 18110.9 d6.25 s15, 17, 18110.9 d6.34 brs15 w, 17, 18
17141.5 d7.20 s15, 16, 18142.6 d7.34 s15, 16, 18142.8 d7.34 brs15, 16
18137.3 d7.10 s15, 16, 17138.4 d7.18 s15, 16, 17138.4 d7.25 brs15, 16, 17
1922.0 q0.85 s7, 8, 9, 1323.3 q0.88 s8, 1330.0 q0.72 s7, 8, 9, 13, 14 w
2015.1 q0.82 d (3.6)8, 9, 1015.9 q0.83 d (6.8)8, 9, 1016.3 q0.81 d (7)8, 9, 10
21 51.9 q3.78 s 1251.8 q3.75 s 12
a Overlapping signals; w weak signal.
Table 3. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, Equilibrium population at 25°C and figures of conformations a-l of the 8R, 9S isomer of dodovisate C (1).
Table 3. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, Equilibrium population at 25°C and figures of conformations a-l of the 8R, 9S isomer of dodovisate C (1).
Conformerabcdef
Figure Molecules 25 00850 i001 Molecules 25 00850 i002 Molecules 25 00850 i003 Molecules 25 00850 i004 Molecules 25 00850 i005 Molecules 25 00850 i006
E (ua) −813.474252−813.473483−813.474156−813.473265−813.472512−813.473392
Dipole moment1.831.771.471.851.811.57
Dihedral angle−111.4°1.2°110.3°−110.7°1.3°110.2°
ΔE (kJ/mol)0.002.020.252.594.572.26
Population (%)30.713.627.710.84.912.3
Conformerghijkl
Figure Molecules 25 00850 i007 Molecules 25 00850 i008 Molecules 25 00850 i009 Molecules 25 00850 i010 Molecules 25 00850 i011 Molecules 25 00850 i012
E (ua)−813.467509−813.466609−813.467563−813.468819−813.467850−813.469001
Dipole moment1.651.661.341.711.721.43
Dihedral angle−111.0°5.4109.1−109.84.3110.0
ΔE (kJ/mol)17.7020.0717.5614.2616.8113.79
Population (%)0.00.00.00.00.00.0
a Include zero-point vibration correction.
Table 4. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations a-l of the 8R, 9R isomer of dodovisate C (1).
Table 4. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations a-l of the 8R, 9R isomer of dodovisate C (1).
Conformera’b’c’d’e’f’
Figure Molecules 25 00850 i013 Molecules 25 00850 i014 Molecules 25 00850 i015 Molecules 25 00850 i016 Molecules 25 00850 i017 Molecules 25 00850 i018
E (ua)−813.463138−813.462352−813.463090−813.464746−813.463918−813.464838
Dipole moment1.761.741.461.821.811.56
Dihedral angle−111.4°4.8°109.4°−110.9°3.5°110.3°
ΔE (kJ/mol)4.466.534.590.242.420.00
Population (%)6.12.75.833.614.037.1
Conformerg’h’i’j’k’l’
Figure Molecules 25 00850 i019 Molecules 25 00850 i020 Molecules 25 00850 i021 Molecules 25 00850 i022 Molecules 25 00850 i023 Molecules 25 00850 i024
E (ua)−813.460304−813.459717−813.460261−813.458557−813.457959−813.4585678
Dipole moment1.951.781.601.971.791.64
Dihedral angle−112.7°1.8°113.4°−111.6°0.9°112.7
ΔE (kJ/mol)11.9113.4512.0216.4918.0616.46
Population (%)0.30.00.30.00.00.0
a Include zero-point vibration correction.
Table 5. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 8S, 9R isomer of methyl dodovisate A (2).
Table 5. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 8S, 9R isomer of methyl dodovisate A (2).
Conformer510411128
Figure Molecules 25 00850 i025 Molecules 25 00850 i026 Molecules 25 00850 i027 Molecules 25 00850 i028 Molecules 25 00850 i029 Molecules 25 00850 i030
E (ua)−1041.381622−1041.380520−1041.381631−1041.380467−1041.379800−1041.380902
Dipole moment1.083.620.873.123.120.35
Dihedral angle−111.6°−112.5°110.5°109.7°3.6°2.4°
ΔE (kJ/mol)3.156.043.126.187.935.04
Population (%)7.22.27.22.11.13.3
Conformer617239
Figure Molecules 25 00850 i031 Molecules 25 00850 i032 Molecules 25 00850 i033 Molecules 25 00850 i034 Molecules 25 00850 i035 Molecules 25 00850 i036
E (ua)−1041.381577−1041.382821−1041.381499−1041.382724−1041.382110−1041.380875
Dipole moment2.921.612.051.730.982.70
Dihedral angle−111.8°−111.8110.4110.41.31.2
ΔE (kJ/mol)3.270.003.470.251.875.11
Population (%)6.825.56.323.012.03.3
a Include zero-point vibration correction.
Table 6. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 8R, 9R isomer of methyl dodovisate A (2).
Table 6. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 8R, 9R isomer of methyl dodovisate A (2).
Conformer425138
Figure Molecules 25 00850 i037 Molecules 25 00850 i038 Molecules 25 00850 i039 Molecules 25 00850 i040 Molecules 25 00850 i041 Molecules 25 00850 i042
E (ua)−1041.379759−1041.380966−1041.379717−1041.381006−1041.380144−1041.378913
Dipole moment3.651.133.120.980.283.20
dihedral angle−112.4°−111.7109.5°110.6°3.7°6.0°
ΔE (kJ/mol)3.270.113.390.002.265.49
Population (%)7.828.07.529.211.73.2
Conformer117106912
Figure Molecules 25 00850 i043 Molecules 25 00850 i044 Molecules 25 00850 i045 Molecules 25 00850 i046 Molecules 25 00850 i047 Molecules 25 00850 i048
E (ua)−1041.378027−1041.379098−1041.378051−1041.379135−1041.378310−1041.377274
Dipole moment2.731.961.931.861.222.61
dihedral angle−111.8°−111.7°109.6°109.5°4.9°4.9°
ΔE (kJ/mol)7.825.017.764.917.089.80
Population (%)1.23.91.34.01.70.5
a Include zero-point vibration correction.
Table 7. Showing linear regressions of theoretical chemical shifts versus experimental values for isomers of dodovisate C (1), methyl dodovisate A (2) and methyl iso-dodovisate A (3) standard errors on the slope, the intercept and the correlation coefficient, Fischer-F statistic factor and standard error of the fit in ppm.
Table 7. Showing linear regressions of theoretical chemical shifts versus experimental values for isomers of dodovisate C (1), methyl dodovisate A (2) and methyl iso-dodovisate A (3) standard errors on the slope, the intercept and the correlation coefficient, Fischer-F statistic factor and standard error of the fit in ppm.
CompoundIsomersSlopeInterceptCoefficient CorrelationFischer-F Statistics in ppm
Dodovisate C (1)8R,9S1.027(7)4.5(6)1.000(6)266611.4
8R,9R1.006(10)8.1(1.0)0.999(10)104402.2
Methyl dodovisate A (2)8R,9S0.9685(7)4.7(7)0.999(7)183421.7
8R,9R0.9453(9)6.2(9)0.999(9)114122.1
Methyl iso-dodovisate A (3)1S,8R,9R0.9405(7)7.0(8)0.999(8)151321.8
1S,8R,9S0.9610(10)4.3(1.0)0.999(10)100072.3
1S,8S,9R0.9479(10)6.2(1.9)0.996(20)25934.4
1S,8S,9S0.9613(13)4.5(1.3)0.998(13)55563.1
Table 8. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 1S,8R,9R isomer of methyl iso-dodovisate A (3).
Table 8. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 1S,8R,9R isomer of methyl iso-dodovisate A (3).
Conformer710912115
Figure Molecules 25 00850 i049 Molecules 25 00850 i050 Molecules 25 00850 i051 Molecules 25 00850 i052 Molecules 25 00850 i053 Molecules 25 00850 i054
E (ua)−1041.365849−1041.365746−1041.365780−1041.364999−1041.365036−1041.366448
Dipole moment2.901.613.201.113.721.01
dihedral angle−114.6°112.0°112.2°1.0°1.0°2.7°
ΔE (kJ/mol)3.443.713.625.685.581.87
Population (%)4.23.73.91.71.77.9
Conformer682143
Figure Molecules 25 00850 i055 Molecules 25 00850 i056 Molecules 25 00850 i057 Molecules 25 00850 i058 Molecules 25 00850 i059 Molecules 25 00850 i060
E (ua)−1041.366428−1041.365784−1041.367137−1041.367160−1041.367124−1041.367129
Dipole moment3,110,820,753,580,702,74
dihedral angle2.8°−114.4°−112.9°−112.9°110.8°110.7°
ΔE (kJ/mol)1.923.610.060.000.100.08
Population (%)7.73.916.316.716.116.2
a include zero-point vibration correction.
Table 9. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-9 of the 1S, 8R, 9S isomer of methyl iso-dodovisate A (3).
Table 9. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-9 of the 1S, 8R, 9S isomer of methyl iso-dodovisate A (3).
Conformer314256
Figure Molecules 25 00850 i061 Molecules 25 00850 i062 Molecules 25 00850 i063 Molecules 25 00850 i064 Molecules 25 00850 i065 Molecules 25 00850 i066
E (ua)−1041.365913−1041.365955−1041.365867−1041.365937−1041.365388−1041.365382
Dipole moment1.213.730.972.881.733.31
dihedral angle−116.4°−116.1°112.4112.2°1.7°2.0°
ΔE (kJ/mol)0.110.000.30.051.491.50
Population (%)17.918.717.018.310.210.2
Conformer897
Figure Molecules 25 00850 i067 Molecules 25 00850 i068 Molecules 25 00850 i069
E (ua)−1041.364092−1041.364040−1041.364102
Dipole moment0.770.762.71
dihedral angle−112.5°110.4110.4°
ΔE (kJ/mol)4.895.034.86
Population (%)2.62.52.6
a include zero-point vibration correction.
Table 10. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 1S, 8S, 9R isomer of methyl iso-dodovisate A (3).
Table 10. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-12 of the 1S, 8S, 9R isomer of methyl iso-dodovisate A (3).
Conformer1251034
Figure Molecules 25 00850 i070 Molecules 25 00850 i071 Molecules 25 00850 i072 Molecules 25 00850 i073 Molecules 25 00850 i074 Molecules 25 00850 i075
E (ua)−1041.369364−1041.368947−1041.367744−1041.367199−1041.368890−1041.368444
Dipole moment2.513.232.362.492.512.60
dihedral angle−105.1°−105.8°2.8°3.9°92.7°97.5
ΔE (kJ/mol)0.001.094.255.681.242.42
Population (%)28.718.5.22.917.410.8
Conformer98127611
Figure Molecules 25 00850 i076 Molecules 25 00850 i077 Molecules 25 00850 i078 Molecules 25 00850 i079 Molecules 25 00850 i080 Molecules 25 00850 i081
E (ua)−1041.367202−1041.367402−1041.366173−1041.367417−1041.367530−1041.366354
Dipole moment2.403.502.502.922.122.69
dihedral angle−107.4°−109.8°−2.1°109.9°111.0°0.6°
ΔE (kJ/mol)5.685.158.385.114.827.90
Population (%)2.93.61.03.74.11.2
a include zero−point vibration correction.
Table 11. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-7 of the 1S, 8S, 9S isomer of methyl iso-dodovisate A (3).
Table 11. Calculated B3LYP/6-311+G(d,p) Energies a, Dipole moments (Debye), relatives Energiesa, (C13-C14-C15-C18) dihedral angle, equilibrium population at 25°C and figures of conformations 1-7 of the 1S, 8S, 9S isomer of methyl iso-dodovisate A (3).
Conformer135624
Figure Molecules 25 00850 i082 Molecules 25 00850 i083 Molecules 25 00850 i084 Molecules 25 00850 i085 Molecules 25 00850 i086 Molecules 25 00850 i087
E (ua)−1041.368995−1041.368611−1041.367491−1041.366883−1041.368632−1041.368189
Dipole moment2,583.242.382.562.572.66
dihedral angle−104.0°−105.3°2.4°3.7°94.4°98.6°
ΔE (kJ/mol)0.001.013.955.550.952.12
Population (%)32.421.66.63.52213.8
Conformer7
Figure Molecules 25 00850 i088
E (ua)−1041.362938
Dipole moment1.89
dihedral angle110.9°
ΔE (kJ/mol)15.90
Population (%)0.1
a include zero-point vibration correction.
Table 12. Sampling data of the studied Dodonea viscosa and percentage yield of the essential oil.
Table 12. Sampling data of the studied Dodonea viscosa and percentage yield of the essential oil.
Voucher NumberCollection Places
(Altitude)
Geographical Coordinates
(GPS System)
DateOil Yield (%)
REU08438Vincendo
(67 m)
21°22′859 S
55°40′108 E
February 20090.10

Share and Cite

MDPI and ACS Style

Marvilliers, A.; Illien, B.; Gros, E.; Sorres, J.; Kashman, Y.; Thomas, H.; Smadja, J.; Gauvin-Bialecki, A. Modified Clerodanes from the Essential Oil of Dodonea viscosa Leaves. Molecules 2020, 25, 850. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules25040850

AMA Style

Marvilliers A, Illien B, Gros E, Sorres J, Kashman Y, Thomas H, Smadja J, Gauvin-Bialecki A. Modified Clerodanes from the Essential Oil of Dodonea viscosa Leaves. Molecules. 2020; 25(4):850. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules25040850

Chicago/Turabian Style

Marvilliers, Arnaud, Bertrand Illien, Emmanuelle Gros, Jonathan Sorres, Yoel Kashman, Hermann Thomas, Jacqueline Smadja, and Anne Gauvin-Bialecki. 2020. "Modified Clerodanes from the Essential Oil of Dodonea viscosa Leaves" Molecules 25, no. 4: 850. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules25040850

Article Metrics

Back to TopTop